-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Investigating Nuclear Transport Inhibition in Myelofibrosis (MF) and Myelodysplastic Neoplasms (MDS)

Sponsor: Karyopharm Therapeutics, Inc
Program: Industry Theaters
Sunday, December 11, 2022: 11:30 AM-12:30 PM
Hall J - Theater 5 (Ernest N. Morial Convention Center)
Reshma Rangwala, MD, PhD, Karyopharm Therapeutics, Inc.
No relevant conflicts of interest to declare.
This presentation is intended for U.S. based registered meeting attendees

For in-person participants only

See more of: Industry Theaters